MedPage Today on MSN
Paradigm Shift for Evaluating, Treating Biochemical Recurrence in Prostate Cancer
When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...
News-Medical.Net on MSN
PSMA PET/CT scans may predict prostate cancer recurrence, guide treatment
New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...
Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of ...
Advanced digital pathology and biopsy analysis are used to identify patients who benefit from intensified prostate cancer treatment. The STAMPEDE trial demonstrated that adding Zytiga to standard ...
Study results are based on Surveillance, Epidemiology, and End Results-Medicare data for 166,581 patients receiving surgery or radiation for localized prostate cancer.
These results suggest that oxybutynin may offer a practical and effective option for managing ADT-associated hot flashes in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results